drugset / Trial / NCT03674203
Efficacy of Platelet-rich Plasma in Treatment of Melasma
NaSingle-groupOpen-labelTreatment
Summary
The application of Platelet Rich Plasma (PRP) on three occasions with an interval of 15 days between each one, is related to a decrease in the intensity of the spots and improvement in the quality of the skin of patients with melasma.
Timeline
- Start
- 2017-05-01
- Primary completion
- 2018-05-31
- Completion
- 2018-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | 1 ml | Other |